Vericel Corporation (VCEL)
After hours:
- GlobeNewswire
Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
CAMBRIDGE, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the appointment of Karen Mahoney as Chief Human Resources Officer following the retirement of Heidi Hassen, who served as Vericel’s Head of Human Resources since September 2010. Ms. Mahoney joins Vericel with more than 20 years of experience across the life sciences and medical device sectors, most recently ser
- GlobeNewswire
Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024
CAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its second-quarter 2024 financial results on Thursday, August 1, 2024. Vericel’s management will host a conference call and webcast at 8:30 a.m. (ET) to discuss its financial results and business highlights. The live webcast can be accessed on the Investor Relations section of the Vericel we
- GuruFocus.com
Insider Sale: CFO Mara Joseph Anthony Jr Sells 5,000 Shares of Vericel Corp (VCEL)
On July 12, 2024, Mara Joseph Anthony Jr, Chief Financial Officer of Vericel Corp (NASDAQ:VCEL), executed a sale of 5,000 shares of the company at a price of $50 per share. Following this transaction, the insider now owns 14,436 shares of Vericel Corp. Vericel Corp specializes in the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions.
